Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
VRDN
$18.34
-0.03%
VRDN
· Viridian Therapeutics, Inc.\DE
$18.34
-0.01 (-0.03%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$2.08B
Shares
113.29M
Volume · Oct 9
53.57K
Avg daily vol (3M)
1.72M
All webcasts
Earnings call · FY2025 Q4
Viridian Therapeutics, Inc.\DE (VRDN) Q4 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$132,000
+83.3% YoY
Net income · derived Q4
-$120.36M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 26, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 26, 2026 · complete as-filed document